BlackBarn Capital Partners LP Purchases 10,600 Shares of Molina Healthcare, Inc. (NYSE:MOH)

BlackBarn Capital Partners LP boosted its position in Molina Healthcare, Inc. (NYSE:MOH) by 25.3% in the second quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The institutional investor owned 52,500 shares of the company’s stock after purchasing an additional 10,600 shares during the period. Molina Healthcare accounts for about 1.4% of BlackBarn Capital Partners LP’s portfolio, making the stock its 3rd biggest holding. BlackBarn Capital Partners LP owned about 0.09% of Molina Healthcare worth $15,608,000 at the end of the most recent reporting period.

Several other large investors have also recently bought and sold shares of MOH. Wellington Management Group LLP increased its stake in shares of Molina Healthcare by 12.8% in the fourth quarter. Wellington Management Group LLP now owns 3,831,100 shares of the company’s stock valued at $1,384,215,000 after buying an additional 436,060 shares during the period. Swedbank AB bought a new stake in Molina Healthcare during the 1st quarter worth approximately $69,320,000. Jupiter Asset Management Ltd. increased its position in Molina Healthcare by 434.6% in the 2nd quarter. Jupiter Asset Management Ltd. now owns 185,606 shares of the company’s stock valued at $55,181,000 after acquiring an additional 150,890 shares during the period. Capital Research Global Investors raised its stake in shares of Molina Healthcare by 5.4% during the fourth quarter. Capital Research Global Investors now owns 2,430,283 shares of the company’s stock valued at $878,086,000 after acquiring an additional 123,894 shares during the last quarter. Finally, Renaissance Technologies LLC lifted its holdings in shares of Molina Healthcare by 13.3% during the second quarter. Renaissance Technologies LLC now owns 949,691 shares of the company’s stock worth $282,343,000 after purchasing an additional 111,154 shares during the period. 98.50% of the stock is currently owned by institutional investors.

Analyst Upgrades and Downgrades

A number of analysts recently weighed in on the company. Stephens restated an “equal weight” rating and issued a $320.00 price objective on shares of Molina Healthcare in a report on Thursday, July 25th. Cantor Fitzgerald reissued an “overweight” rating and issued a $406.00 price target on shares of Molina Healthcare in a research note on Tuesday, September 10th. Baird R W raised Molina Healthcare to a “strong-buy” rating in a research note on Thursday, May 30th. Deutsche Bank Aktiengesellschaft decreased their target price on shares of Molina Healthcare from $354.00 to $353.00 and set a “hold” rating for the company in a research report on Monday, July 29th. Finally, Jefferies Financial Group lowered their price target on shares of Molina Healthcare from $354.00 to $297.00 and set a “hold” rating for the company in a report on Wednesday, July 24th. One investment analyst has rated the stock with a sell rating, seven have given a hold rating, five have given a buy rating and one has issued a strong buy rating to the company. Based on data from MarketBeat, the stock has a consensus rating of “Hold” and an average price target of $378.00.

Insiders Place Their Bets

In other news, Director Steven J. Orlando sold 1,000 shares of the company’s stock in a transaction that occurred on Tuesday, July 30th. The stock was sold at an average price of $339.21, for a total transaction of $339,210.00. Following the transaction, the director now directly owns 18,025 shares of the company’s stock, valued at $6,114,260.25. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is available through the SEC website. In other news, CAO Maurice Hebert sold 393 shares of Molina Healthcare stock in a transaction dated Thursday, August 15th. The shares were sold at an average price of $346.52, for a total transaction of $136,182.36. Following the completion of the transaction, the chief accounting officer now directly owns 9,473 shares in the company, valued at $3,282,583.96. The sale was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through this link. Also, Director Steven J. Orlando sold 1,000 shares of the firm’s stock in a transaction dated Tuesday, July 30th. The shares were sold at an average price of $339.21, for a total transaction of $339,210.00. Following the completion of the transaction, the director now directly owns 18,025 shares in the company, valued at approximately $6,114,260.25. The disclosure for this sale can be found here. Corporate insiders own 1.10% of the company’s stock.

Molina Healthcare Stock Down 0.5 %

Molina Healthcare stock opened at $346.29 on Wednesday. The company has a market capitalization of $20.29 billion, a PE ratio of 18.79, a PEG ratio of 1.21 and a beta of 0.57. Molina Healthcare, Inc. has a 12-month low of $282.96 and a 12-month high of $423.92. The firm’s fifty day moving average is $337.66 and its 200 day moving average is $342.19. The company has a quick ratio of 1.57, a current ratio of 1.57 and a debt-to-equity ratio of 0.49.

Molina Healthcare (NYSE:MOH) last released its quarterly earnings data on Wednesday, July 24th. The company reported $5.86 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $5.73 by $0.13. The company had revenue of $9.88 billion for the quarter, compared to analysts’ expectations of $9.75 billion. Molina Healthcare had a net margin of 2.84% and a return on equity of 28.09%. The business’s revenue was up 18.7% on a year-over-year basis. During the same quarter in the prior year, the firm earned $5.65 EPS. As a group, sell-side analysts predict that Molina Healthcare, Inc. will post 23.5 EPS for the current fiscal year.

Molina Healthcare Profile

Molina Healthcare, Inc provides managed healthcare services to low-income families and individuals under the Medicaid and Medicare programs and through the state insurance marketplaces. It operates in four segments: Medicaid, Medicare, Marketplace, and Other. The company served in across 19 states. The company was founded in 1980 and is headquartered in Long Beach, California.